Latest for Guillain-Barré Syndrome
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
More about Guillain-Barré Syndrome
GBS is usually triggered by a preceding infection, most commonly Campylobacter jejuni gastroenteritis, but also by respiratory viruses, cytomegalovirus, Epstein-Barr virus, and Zika virus. The immune response generated against the pathogen cross-reacts with gangliosides or other components on peripheral nerve membranes through molecular mimicry.
Keep reading about Guillain-Barré Syndrome
Treatment with intravenous immunoglobulin (IVIG) or plasma exchange can shorten the course and severity. About 80% of patients can walk on their own again within 6 months, though full recovery can take months to years and many keep some weakness, pain or fatigue. Approximately 5% of cases are fatal, usually from respiratory failure or cardiac complications.
What are the symptoms of Guillain-Barré Syndrome?
These are common symptoms of Guillain-Barré Syndrome, and how strong they are varies from person to person.
- Tingling or weakness starting in the feet and legs, spreading upward
- Difficulty walking, climbing stairs, or using facial muscles
- Muscle weakness affecting both sides of the body
- Chest weakness that may affect breathing
- Deep muscle pain, especially in back and legs
- Changes in blood pressure or heart rate
Who gets Guillain-Barré Syndrome?
Can occur at any age but is slightly more common in adults over 50 and in males. Often develops days or weeks after a respiratory or gastrointestinal infection, particularly Campylobacter jejuni. Rare cases have been associated with certain vaccinations or surgical procedures.
Next steps: find trials you might fitsee what is being testedget help payingget alerts
Which new Guillain-Barré Syndrome medicines are in trials?
Investigational medicines Trial Friend tracks for Guillain-Barré Syndrome, with trial results, safety findings and where each one stands.
How to get help paying for Guillain-Barré Syndrome treatment
Charity funds and drugmaker programs for Guillain-Barré Syndrome, checked at the source.
- From a charity · NORD RareCareGuillain-Barre Emergency Relief Assistance fundOpen
Pays for: Emergency relief.
The foundation says: “Accepting Applications”
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
How Guillain-Barré Syndrome is diagnosed
A post-infectious immune attack on peripheral nerves; almost all cases are sporadic and no genetic test has a role.
Trusted Guillain-Barré Syndrome resources
Reputable organizations and medical references for learning more about Guillain-Barré Syndrome, including disease registries, foundation resources, and clinical guidelines.